Mitochondrial Crisis in Cerebrovascular Endothelial Cells Opens the Blood-Brain Barrier

Stroke

Volumn 46, Issue 6, 2015, Pages 1681-1689

  Doll, Danielle N ^a   Hu, Heng ^a   Sun, Jiahong ^a   Lewis, Sara E ^a   Simpkins, James W ^a   Ren, Xuefang ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

blood brain barrier; mitochondria; stroke

Indexed keywords

LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOTHELIUM CELL; FUNCTIONAL ASSESSMENT; IN VITRO STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; ANIMAL; CAPILLARY PERMEABILITY; DRUG EFFECTS; ELECTRON TRANSPORT; METABOLISM; MITOCHONDRION; PATHOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; ELECTRON TRANSPORT; ENDOTHELIAL CELLS; LIPOPOLYSACCHARIDES; MICE; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; STROKE;

EID: 84942850510     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009099     Document Type: Article

References (30)

1. Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci. 1999;22:11-28. doi: 10.1146/annurev.neuro.22.1.11.
2. González-Mariscal L, Betanzos A, Avila-Flores A. MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol. 2000;11:315-324. doi: 10.1006/scdb.2000.0178.
3. Tajes M, Ramos-Fernández E, Weng-Jiang X, Bosch-Morató M, Guivernau B, Eraso-Pichot A, et al. The blood-brain barrier: structure, function and therapeutic approaches to cross it. Mol Membr Biol. 2014;31:152-167. doi: 10.3109/09687688.2014.937468.
4. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245-254.
5. Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C, Banerjee T, Maiwald M, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke. 1995;26:373-379.
6. Grau AJ, Buggle F, Steichen-Wiehn C, Heindl S, Banerjee T, Seitz R, et al. Clinical and biochemical analysis in infection-associated stroke. Stroke. 1995;26:1520-1526.
7. McColl BW, Rothwell NJ, Allan SM. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1-and neutrophil-dependent mechanisms. J Neurosci. 2007;27:4403-4412. doi:10.1523/JNEUROSCI.5376-06.2007.
8. Banks WA, Erickson MA. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis. 2010;37:26-32. doi: 10.1016/j. nbd.2009.07.031.
9. Dénes A, Ferenczi S, Kovács KJ. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation. 2011;8:164. doi:10.1186/1742-2094-8-164.
10. Sims NR, Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta. 2010;1802:80-91. doi: 10.1016/j. bbadis.2009.09.003.
11. Sims NR, Anderson MF. Mitochondrial contributions to tissue damage in stroke. Neurochem Int. 2002;40:511-526.
12. Harhausen D, Khojasteh U, Stahel PF, Morgan BP, Nietfeld W, Dirnagl U, et al. Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice. J Neuroinflammation. 2010;7:15. doi:10.1186/1742-2094-7-15.
13. Brown RC, Morris AP, O'Neil RG. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res. 2007;1130:17-30. doi: 10.1016/j.brainres.2006.10.083.
14. Artursson P. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci. 1990;79:476-482.
15. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis. 2008;32:200-219. doi: 10.1016/j. nbd.2008.08.005.
16. Nag S, Kapadia A, Stewart DJ. Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol. 2011;37:3-23. doi: 10.1111/j.1365-2990.2010.01138.x.
17. Hu H, Jun S, Sarkar SN, Doll DN, Ren X, Simpkins JW. Dynamic bloodbrain barrier openings concur with increasing of mir-let7a in murine experimental stroke. Soc Neurosci. 2014;701.05.
18. Gee JM, Kalil A, Shea C, Becker KJ. Lymphocytes: potential mediators of postischemic injury and neuroprotection. Stroke. 2007;38(2 suppl):783-788. doi: 10.1161/01.STR.0000248425.59176.7b.
19. Gay NJ, Symmons MF, Gangloff M, Bryant CE. Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol. 2014;14:546-558. doi: 10.1038/nri3713.
20. Palasik W, Fiszer U, Lechowicz W, Czartoryska B, Krzesiewicz M, Lugowska A. Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters. Eur Neurol. 2005;53:188-193. doi: 10.1159/000086355.
21. Kim Y, Zhou P, Qian L, Chuang JZ, Lee J, Li C, et al. MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival. J Exp Med. 2007;204:2063-2074. doi: 10.1084/jem.20070868.
22. Banks WA, Dohgu S, Lynch JL, Fleegal-DeMotta MA, Erickson MA, Nakaoke R, et al. Nitric oxide isoenzymes regulate lipopolysaccharideenhanced insulin transport across the blood-brain barrier. Endocrinology. 2008;149:1514-1523. doi: 10.1210/en.2007-1091.
23. Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42:3323-3328. doi:10.1161/STROKEAHA.110.608257.
24. Taheri S, Candelario-Jalil E, Estrada EY, Rosenberg GA. Spatiotemporal correlations between blood-brain barrier permeability and apparent diffusion coefficient in a rat model of ischemic stroke. PLoS One. 2009;4:e6597. doi: 10.1371/journal.pone.0006597.
25. Bektas H, Wu TC, Kasam M, Harun N, Sitton CW, Grotta JC, et al. Increased blood-brain barrier permeability on perfusion CT might predict malignant middle cerebral artery infarction. Stroke. 2010;41:2539-2544. doi: 10.1161/STROKEAHA.110.591362.
26. Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 2004;35 (11 suppl 1):2659-2661. doi: 10.1161/01.STR.0000144051.32131.09.
27. Doll DN, Rellick SL, Barr TL, Ren X, Simpkins JW. Rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity. J Neurochem. 2015;132:443-451. doi: 10.1111/jnc.13008.
28. Drabarek B, Dymkowska D, Szczepanowska J, Zabocki K. TNF affects energy metabolism and stimulates biogenesis of mitochondria in EA.hy926 endothelial cells. Int J Biochem Cell Biol. 2012;44:1390-1397. doi: 10.1016/j.biocel.2012.05.022.
29. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, et al. Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect. 2011;119:866-872. doi: 10.1289/ehp.1002839.
30. Chesselet MF, Richter F. Modelling of Parkinson's disease in mice. Lancet Neurol. 2011;10:1108-1118. doi: 10.1016/S1474-4422(11)70227-7.